Exact Mass: 314.0553

Exact Mass Matches: 314.0553

Found 91 metabolites which its exact mass value is equals to given mass value 314.0553, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

rofecoxib

rofecoxib

C17H14O4S (314.0613)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C80509 - COX-2 Inhibitor D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor COVID info from COVID-19 Disease Map D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Nuarimol

Pesticide6_Nuarimol_C17H12ClFN2O_(2-Chlorophenyl)(4-fluorophenyl)5-pyrimidinylmethanol

C17H12ClFN2O (314.0622)


CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8953; ORIGINAL_PRECURSOR_SCAN_NO 8952 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4396; ORIGINAL_PRECURSOR_SCAN_NO 4394 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8962; ORIGINAL_PRECURSOR_SCAN_NO 8959 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8997; ORIGINAL_PRECURSOR_SCAN_NO 8995 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4376; ORIGINAL_PRECURSOR_SCAN_NO 4372 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8980; ORIGINAL_PRECURSOR_SCAN_NO 8977 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4391; ORIGINAL_PRECURSOR_SCAN_NO 4388 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4409; ORIGINAL_PRECURSOR_SCAN_NO 4405 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8992; ORIGINAL_PRECURSOR_SCAN_NO 8990 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9005; ORIGINAL_PRECURSOR_SCAN_NO 9001 CONFIDENCE standard compound; INTERNAL_ID 1244; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4406; ORIGINAL_PRECURSOR_SCAN_NO 4404 D016573 - Agrochemicals D010575 - Pesticides

   

Malaoxon

1,4-diethyl 2-[(dimethoxyphosphoryl)sulfanyl]butanedioate

C10H19O7PS (314.0589)


Malaoxon is a metabolite of malathion. Malaoxon is a chemical compound with the formula C10H19O7PS. More specifically, it is a phosphorothioate. It is a breakdown product of, and more toxic than, malathion. (Wikipedia) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3713 D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Dantrolene

1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)imidazolidine-2,4-dione

C14H10N4O5 (314.0651)


Dantrolene is only found in individuals that have used or taken this drug.Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin.Dantrolene depresses excitation-contraction coupling in skeletal muscle by binding to the ryanodine receptor 1, and decreasing intracellular calcium concentration. Ryanodine receptors mediate the release of calcium from the sarcoplasmic reticulum, an essential step in muscle contraction. M - Musculo-skeletal system > M03 - Muscle relaxants > M03C - Muscle relaxants, directly acting agents > M03CA - Dantrolene and derivatives D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant D002491 - Central Nervous System Agents

   

5'-Phosphoribosyl-N-formylglycinamide

{[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-formamidoacetamido)oxolan-2-yl]methoxy}phosphonic acid

C8H15N2O9P (314.0515)


5-phosphoribosyl-n-formylglycinamide, also known as N-formyl-gar or N-formylglycinamide ribonucleotide, is a member of the class of compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. 5-phosphoribosyl-n-formylglycinamide is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5-phosphoribosyl-n-formylglycinamide can be found in a number of food items such as rosemary, mexican groundcherry, common wheat, and bitter gourd, which makes 5-phosphoribosyl-n-formylglycinamide a potential biomarker for the consumption of these food products. 5-phosphoribosyl-n-formylglycinamide exists in all living species, ranging from bacteria to humans. In humans, 5-phosphoribosyl-n-formylglycinamide is involved in few metabolic pathways, which include azathioprine action pathway, mercaptopurine action pathway, purine metabolism, and thioguanine action pathway. 5-phosphoribosyl-n-formylglycinamide is also involved in several metabolic disorders, some of which include mitochondrial DNA depletion syndrome, aICA-Ribosiduria, molybdenum cofactor deficiency, and xanthinuria type I. 5-Phosphoribosyl-N-formylglycinamide, also known as FGAR or N-formyl-GAR, belongs to the class of organic compounds known as glycinamide ribonucleotides. Glycinamide ribonucleotides are compounds in which the amide N atom of glycineamide is linked to the C-1 of a ribosyl (or deoxyribosyl) moiety. FGAR is an extremely weak basic (essentially neutral) compound (based on its pKa). FGAR is a substrate for phosphoribosylformylglycinamidine synthase. It is involved in aminoimidazole ribonucleotide biosynthesis and plays a vital role in purine metabolism as well as in the conversion of glutamine to glutamate.

   

Clorazepate

7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid

C16H11ClN2O3 (314.0458)


Clorazepate is only found in individuals that have used or taken this drug. It is a water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

MBS Crosslinker

3-Maleimidobenzoyl N-hydroxysuccinimide

C15H10N2O6 (314.0539)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

3,4,5-trihydroxy-6-(4-hydroxybenzoyloxy)oxane-2-carboxylic acid

3,4,5-trihydroxy-6-(4-hydroxybenzoyloxy)oxane-2-carboxylic acid

C13H14O9 (314.0638)


   

6-(4-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O9 (314.0638)


6-(4-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 4-hydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

1-Salicylate glucuronide

(2S,3S,4S,5R,6S)-6-(2-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O9 (314.0638)


1-salicylate glucuronide is a natural human metabolite of 1-salicylate generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] 1-salicylate glucuronide is a natural human metabolite of 1-salicylate generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

Beta-D-Glucopyranuronic acid

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxybenzoyloxy)oxane-2-carboxylic acid

C13H14O9 (314.0638)


Salicylacyl glucuronide is a natural human metabolite of acetylsilacylic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] Salicylacyl glucuronide is a natural human metabolite of acetylsilacylic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

6-(3-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O9 (314.0638)


6-(3-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 3-hydroxybenzoic acid. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.

   

3-Maleimidobenzoic acid N-hydroxysuccinimide ester

2,5-dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate

C15H10N2O6 (314.0539)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

5-Hydroxy-3-[[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1H-imidazol-2-one

4-hydroxy-1-({[5-(4-nitrophenyl)furan-2-yl]methylidene}amino)-2,3-dihydro-1H-imidazol-2-one

C14H10N4O5 (314.0651)


   

Norbergenin

Pyrano(3,2-c)(2)benzopyran-6(2H)-one, 3,4,4a,10b-tetrahydro-3,4,8,9,10-pentahydroxy-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,4aalpha,10bbeta))-

C13H14O9 (314.0638)


(2S,3R,4R,4aS,10bR)-3,4,8,9,10-pentahydroxy-2-(hydroxymethyl)-3,4,4a,10b-tetrahydro-2H-pyrano[3,2-c]isochromen-6-one is a natural product found in Ardisia paniculata, Saxifraga stolonifera, and other organisms with data available. Norbergenin, the O-demethyl derivative of bergenin, shows moderate antioxidant activity (IC50 13 μM in DPPH radical scavenging; 32 μM in superoxide anion scavenging)[1]. Norbergenin, the O-demethyl derivative of bergenin, shows moderate antioxidant activity (IC50 13 μM in DPPH radical scavenging; 32 μM in superoxide anion scavenging)[1].

   
   

Syringoylmalic acid

Syringoylmalic acid

C13H14O9 (314.0638)


   
   

4-{5-[(4-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine

4-{5-[(4-nitrobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine

C14H10N4O3S (314.0474)


   

Cyathenosin A

Cyathenosin A

C13H14O9 (314.0638)


   

2--5-<3,4-diacetoxy-butin-(1)-yl>-thiophen|2-Hydroxy,di-Ac-4-[5-(1,3-Pentadiynyl)-7-thienyl]-3-butyn-1-ol|3,4-diacetoxy-1-(5-penta-1,3-diynyl-thiophen-2-yl)-but-1-yne

2--5-<3,4-diacetoxy-butin-(1)-yl>-thiophen|2-Hydroxy,di-Ac-4-[5-(1,3-Pentadiynyl)-7-thienyl]-3-butyn-1-ol|3,4-diacetoxy-1-(5-penta-1,3-diynyl-thiophen-2-yl)-but-1-yne

C17H14O4S (314.0613)


   

SCHEMBL15544472

SCHEMBL15544472

C20H10O4 (314.0579)


   

CHEMBL90097

CHEMBL90097

C20H10O4 (314.0579)


   

6-O-galloyl-beta-glucose-1,3-oxide

6-O-galloyl-beta-glucose-1,3-oxide

C13H14O9 (314.0638)


   

Rofecoxib (Vioxx)

Rofecoxib (Vioxx)

C17H14O4S (314.0613)


   

dantrolene

Dantrolenum; Dantrium; Dantrolenum

C14H10N4O5 (314.0651)


M - Musculo-skeletal system > M03 - Muscle relaxants > M03C - Muscle relaxants, directly acting agents > M03CA - Dantrolene and derivatives D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D002491 - Central Nervous System Agents CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3945; ORIGINAL_PRECURSOR_SCAN_NO 3940 CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3956; ORIGINAL_PRECURSOR_SCAN_NO 3954 CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3932; ORIGINAL_PRECURSOR_SCAN_NO 3929 CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3942; ORIGINAL_PRECURSOR_SCAN_NO 3939 CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3694; ORIGINAL_PRECURSOR_SCAN_NO 3692 CONFIDENCE standard compound; INTERNAL_ID 992; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3687; ORIGINAL_PRECURSOR_SCAN_NO 3685

   

Salicyl phenolic glucuronide

Salicyl phenolic glucuronide

C13H14O9 (314.0638)


   

Salicyl acyl glucuronide

Salicyl acyl glucuronide

C13H14O9 (314.0638)


   

Met-Gly-OH

2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)acetic acid

C12H14N2O6S (314.0573)


   

Gly-Met-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C12H14N2O6S (314.0573)


   

1-(trans-4-Ethylcyclohexyl)-4-iodobenzene

1-(trans-4-Ethylcyclohexyl)-4-iodobenzene

C14H19I (314.0531)


   

2-BROMO-4-ISOPROPYLPHENYLISOTHIOCYANATE

2-BROMO-4-ISOPROPYLPHENYLISOTHIOCYANATE

C10H10F8O2 (314.0553)


   

4-phenylmethoxynaphthalene-1-sulfonic acid

4-phenylmethoxynaphthalene-1-sulfonic acid

C17H14O4S (314.0613)


   

3-phenyl-2-sulfanylidene-5,6,7,8-tetrahydro-1H-[1]benzothiolo[2,3-d]pyrimidin-4-one

3-phenyl-2-sulfanylidene-5,6,7,8-tetrahydro-1H-[1]benzothiolo[2,3-d]pyrimidin-4-one

C16H14N2OS2 (314.0548)


   

Methyl 4-(5-nitro-6-hydroxylbenzoxazol-2-yl)benzate

Methyl 4-(5-nitro-6-hydroxylbenzoxazol-2-yl)benzate

C15H10N2O6 (314.0539)


   

tert-butyl N-[2-amino-2-(4-bromophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(4-bromophenyl)ethyl]carbamate

C13H19BrN2O2 (314.063)


   

Tesicam

4-Isoquinolinecarboxamide,N-(4-chlorophenyl)-1,2,3,4-tetrahydro-1,3-dioxo-

C16H11ClN2O3 (314.0458)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

1-[4-(METHYLSULFONYL)-2-NITROPHENYL]PYRROLIDINE-2-CARBOXYLIC ACID

1-[4-(METHYLSULFONYL)-2-NITROPHENYL]PYRROLIDINE-2-CARBOXYLIC ACID

C12H14N2O6S (314.0573)


   

1-[(2-nitrophenyl)sulfonyl]piperidine-2-carboxylic acid

1-[(2-nitrophenyl)sulfonyl]piperidine-2-carboxylic acid

C12H14N2O6S (314.0573)


   

2-Bromomethyl-4-fluorophenylboronic acid pinacol ester

2-Bromomethyl-4-fluorophenylboronic acid pinacol ester

C13H17BBrFO2 (314.0489)


   

tert-butyl-(4-iodobutoxy)-dimethylsilane

tert-butyl-(4-iodobutoxy)-dimethylsilane

C10H23IOSi (314.0563)


   

(5-CHLORO-2-METHYL-1H-INDOL-3-YL)-ACETICACID

(5-CHLORO-2-METHYL-1H-INDOL-3-YL)-ACETICACID

C13H15ClN2O3S (314.0492)


   

2,6-dichloro-N-[2-(4-oxopiperidin-1-yl)ethyl]benzamide

2,6-dichloro-N-[2-(4-oxopiperidin-1-yl)ethyl]benzamide

C14H16Cl2N2O2 (314.0589)


   

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BBrFO2 (314.0489)


   

2-(4-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C13H17BBrFO2 (314.0489)


   

1-[4-(3-bromopropoxy)-2-hydroxy-3-propylphenyl]ethanone

1-[4-(3-bromopropoxy)-2-hydroxy-3-propylphenyl]ethanone

C14H19BrO3 (314.0517)


   

tert-butyl N-[2-amino-2-(2-bromophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(2-bromophenyl)ethyl]carbamate

C13H19BrN2O2 (314.063)


   

METHYL 4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLATE

METHYL 4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLATE

C13H9F3N2O4 (314.0514)


   

1-(4-Ethylcyclohexyl)-4-iodobenzene

1-(4-Ethylcyclohexyl)-4-iodobenzene

C14H19I (314.0531)


   

2H-Pyran, 4-[(1R)-2-bromo-1-(2-methoxyphenyl)ethoxy]tetrahydro-

2H-Pyran, 4-[(1R)-2-bromo-1-(2-methoxyphenyl)ethoxy]tetrahydro-

C14H19BrO3 (314.0517)


   

(E)-4-nitrophenyl 3-(4-nitrophenyl)acrylate

(E)-4-nitrophenyl 3-(4-nitrophenyl)acrylate

C15H10N2O6 (314.0539)


   

2-(3-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(3-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C13H17BBrFO2 (314.0489)


   

2-(5-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(5-(BROMOMETHYL)-2-FLUOROPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C13H17BBrFO2 (314.0489)


   

3-(6-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propanoic acid

3-(6-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propanoic acid

C15H10N2O6 (314.0539)


   

(Z)-5-((1-(4-nitrophenyl)-1H-pyrrol-2-yl)methylene)-2-thioxoimidazolidin-4-one

(Z)-5-((1-(4-nitrophenyl)-1H-pyrrol-2-yl)methylene)-2-thioxoimidazolidin-4-one

C14H10N4O3S (314.0474)


   
   

1-benzyl-4-chloro-3-nitroquinolin-2(1H)-one

1-benzyl-4-chloro-3-nitroquinolin-2(1H)-one

C16H11ClN2O3 (314.0458)


   
   
   

3-Aza-2,3-dihydrogeranyl diphosphate

3-Aza-2,3-dihydrogeranyl diphosphate

C9H18NO7P2-3 (314.0558)


   

5-S-cysteinyldopaquinone

5-S-cysteinyldopaquinone

C12H14N2O6S (314.0573)


   

2-S-cysteinyldopaquinone

2-S-cysteinyldopaquinone

C12H14N2O6S (314.0573)


   

p-nitrophenyl-alpha-D-glucuronide

p-nitrophenyl-alpha-D-glucuronide

C12H12NO9- (314.0512)


   

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylate

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxane-2-carboxylate

C12H12NO9- (314.0512)


   

(2S)-2-amino-3-[2-[(2R)-2-amino-2-carboxyethyl]sulfanyl-3,4-dioxocyclohexa-1,5-dien-1-yl]propanoic acid

(2S)-2-amino-3-[2-[(2R)-2-amino-2-carboxyethyl]sulfanyl-3,4-dioxocyclohexa-1,5-dien-1-yl]propanoic acid

C12H14N2O6S (314.0573)


   

(2S)-2-amino-3-[5-[(2R)-2-amino-2-carboxyethyl]sulfanyl-3,4-dioxocyclohexa-1,5-dien-1-yl]propanoic acid

(2S)-2-amino-3-[5-[(2R)-2-amino-2-carboxyethyl]sulfanyl-3,4-dioxocyclohexa-1,5-dien-1-yl]propanoic acid

C12H14N2O6S (314.0573)


   

5-Hydroxy-3-[[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1H-imidazol-2-one

5-Hydroxy-3-[[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1H-imidazol-2-one

C14H10N4O5 (314.0651)


   

N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide

N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide

C8H15N2O9P (314.0515)


A glycinamide ribonucleotide having a phosphate group at the 5-position and a formyl group on the glycine nitrogen.

   

5-chloropyridin-3-yl 1-acetyl-1H-indole-5-carboxylate

5-chloropyridin-3-yl 1-acetyl-1H-indole-5-carboxylate

C16H11ClN2O3 (314.0458)


   

4-(4-Chlorophenyl)-2-(2-propyl-4-pyridinyl)thiazole

4-(4-Chlorophenyl)-2-(2-propyl-4-pyridinyl)thiazole

C17H15ClN2S (314.0644)


   

5-chloropyridin-3-yl 1-acetyl-1H-indole-4-carboxylate

5-chloropyridin-3-yl 1-acetyl-1H-indole-4-carboxylate

C16H11ClN2O3 (314.0458)


   
   

Edetate monomagnesium

Edetate monomagnesium

C10H14MgN2O8 (314.0601)


   

3,4,5-Trihydroxy-6-(3-hydroxybenzoyl)oxyoxane-2-carboxylic acid

3,4,5-Trihydroxy-6-(3-hydroxybenzoyl)oxyoxane-2-carboxylic acid

C13H14O9 (314.0638)


   

[2-Hydroxy-1-(1-oxoisochromen-3-yl)butyl] hydrogen sulate

[2-Hydroxy-1-(1-oxoisochromen-3-yl)butyl] hydrogen sulate

C13H14O7S (314.046)


   

MALAOXON

MALAOXON

C10H19O7PS (314.0589)


D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Clorazepic acid

Clorazepic acid

C16H11ClN2O3 (314.0458)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

1-Salicylate glucuronide

1-Salicylate glucuronide

C13H14O9 (314.0638)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates A beta-D-glucosiduronic acid that is the glucuronide conjugate of salicyclic acid.

   

6-(3-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(3-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H14O9 (314.0638)


   

Salicylate glucuronide

Salicylate glucuronide

C13H14O9 (314.0638)


   

Lu AF21934

Lu AF21934

C14H16Cl2N2O2 (314.0589)


Lu AF21934 is a selective and brain-penetrant mGlu4 receptor positive allosteric modulator with an EC50 of 500 nM for mGlu4 receptor[1].

   

methyl 7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10h-phenazine-1-carboxylate

methyl 7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10h-phenazine-1-carboxylate

C15H10N2O6 (314.0539)


   

(2r,4s,5r,6r,7s)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

(2r,4s,5r,6r,7s)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

C13H14O9 (314.0638)


   

methyl (6e)-7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10h-phenazine-1-carboxylate

methyl (6e)-7-hydroxy-6-(hydroxymethylidene)-4,9-dioxo-10h-phenazine-1-carboxylate

C15H10N2O6 (314.0539)


   

[1,2'-binaphthalene]-5,5',8,8'-tetrone

[1,2'-binaphthalene]-5,5',8,8'-tetrone

C20H10O4 (314.0579)


   

methyl 6-formyl-4,7-dihydroxy-9-oxo-5h-phenazine-1-carboxylate

methyl 6-formyl-4,7-dihydroxy-9-oxo-5h-phenazine-1-carboxylate

C15H10N2O6 (314.0539)


   

(2s,4r,5r,6s,7r)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

(2s,4r,5r,6s,7r)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

C13H14O9 (314.0638)


   

(2s,4r,5r,6s,7s)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

(2s,4r,5r,6s,7s)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

C13H14O9 (314.0638)


   

4,5,12,13,14-pentahydroxy-2,9,15-trioxatricyclo[9.3.1.1³,⁷]hexadeca-3(16),4,6-trien-8-one

4,5,12,13,14-pentahydroxy-2,9,15-trioxatricyclo[9.3.1.1³,⁷]hexadeca-3(16),4,6-trien-8-one

C13H14O9 (314.0638)


   

(1s,11r,12s,13s,14r)-4,5,12,13,14-pentahydroxy-2,9,15-trioxatricyclo[9.3.1.1³,⁷]hexadeca-3(16),4,6-trien-8-one

(1s,11r,12s,13s,14r)-4,5,12,13,14-pentahydroxy-2,9,15-trioxatricyclo[9.3.1.1³,⁷]hexadeca-3(16),4,6-trien-8-one

C13H14O9 (314.0638)


   

5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-9-one

C13H14O9 (314.0638)